TV-5010

TV-5010 is a higher molecular weight version of glatiramer acetate, a synthetic polypeptide composed of L-glutamic acid, L-alanine, L-lysine, and L-tyrosine. It is designed to act as an immunomodulator and has been investigated primarily for the treatment of autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. The mechanism of action involves modulation of immune responses by mimicking myelin basic protein, thereby shifting T-cell populations from pro-inflammatory Th1 to anti-inflammatory Th2 phenotypes. This reduces demyelination and neuroinflammation in conditions like multiple sclerosis[1][3][4]. TV-5010 was developed as an improved or alternative formulation to standard glatiramer acetate with potentially enhanced efficacy or altered pharmacokinetics due to its higher molecular weight[1][3].

Other names

Glatiramer acetate (higher molecular weight version)Copaxone (reference drug, not identical but related)Glatirameracetat